1World Health Organization. Global tuberculosis control. WHO/HTM/TB/201116 2011. Geneva: World Health Or- ganization, 2011. 被引量：1
2World Health Organization. Anti Tuberculosis drug resistance in the world., the WHO/IUATLD global project on anti tuber- culosis drug resistance surveillance, 1994-1997. Geneva: World Health Organization, 1997: 154-227. 被引量：1
3World Health Organization. Towards universal access to diag nosis and treatment of multi drug-resistant and extensively drug resistant tuberculosis by 2015. WHO/HTM/TB/ 2011.3. 被引量：1
4Geneva: World Health Organization,2011. Perez-Velez CM. Pediatric tuberculosis: new guidelines and recommendations. Curr Opin Pediatr, 2012, 24(3) :319- 328. 被引量：1
5Shah I. Multidrug-resistant tuberculosis in children. Pediatr Infect Dis J, 2012, 31(9):970-972. 被引量：1
9Blakemore R,Story E, Helb D, et al. Evaluatio of the analyti- cal performance of the Xpert MTB/RIF assay. J Clin Micro- biol, 2010, 48(7): 2495-2501. 被引量：1
5Donah PR.Hhiklhood yuberculosis out of control.Curt Opin pulm Mel,2002,8:178-182. 被引量：1
6Fourie P,Becker P,Festenste F,et al.Procedures for developing asiple scoring method on unsophisticated criteria forsereening chiklren for tubreculosis.Int Jtuberc Lung Dis,1998,2:116-123. 被引量：1
7Lienhardt C,Silah J,Fielding K,et al.Risk factors for tuberculosis infection in chidren in contact with infections tuberculosis cases in zhe Gambin West Africa.Pedliatrics,2003,111:608-614. 被引量：1
8Watkins RE,Brennan R,Olant AJ.Tubeculinreactivity and zhe risk of tuberculosis:a review int j yuberc.Dis,2000,4:895-903. 被引量：1
9Podiatric Tuberculisis Collabortive Group.Targeted tuberculin skin testing and treament of latent tuberculosis infection in children and adolescents.Pediatrics,2004,114:1175-1201. 被引量：1
